Super2 title contender Thomas Randle has said that the postponement in his season will not manipulate his approach to his recovery from testicular cancer.
The Super2 season kickstarted in Adelaide with Randle coming out of the weekend second in the championship, two points adrift of leader Brodie Kostecki.
Round two was scheduled to be held from the Tyrepower Tasmania Super400, but now it looks like the next time the Super2 series will hit the track won’t be until Townsville in late June.
But in an interview with supercars.com, Randle stressed that his health has always been his top priority, saying that he would never delay chemotherapy in order to race.
“The misconception is that people are thinking that I’m delaying the chemo to race and that is not true,” he told Supercars.com.
“I mean, you have got to put your health first and the fact is at the moment the tumour marker numbers are too low for the oncologist to go ahead with any form of chemotherapy.
“At the moment it’s not required. I’m now on a month-to-month check-up, which is a lot better than having to do chemo.
“But it wasn’t like ‘oh we’ve got Tassie, let’s delay [chemotherapy].
“It was more actually we can race because the treatment is not required in what we believe to be the immediate future, which is fantastic.”
Randle also highlighted that his road to recovery is a two-year affair that will require constant monitoring and blood tests.
“Every month will be blood tests, and then I think every three months will be a CT scan,” he said.
“Basically I have got to do this for two years and if in that period it doesn’t return, then it’s highly unlikely for it to return again in my lifetime.”
Randle will have another stint at this year’s PIRTEK Enduro Cup, switching from Tickford to Brad Jones Racing where he will partner Nick Percat.